We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+10.07%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$84.1B
AUM Growth
+$4.28B
Cap. Flow
-$1.24B
Cap. Flow %
-1.48%
Top 10 Hldgs %
54.05%
Holding
789
New
67
Increased
250
Reduced
339
Closed
77

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$231M
2
AMZN icon
Amazon
AMZN
+$230M
3
ALSN icon
Allison Transmission
ALSN
+$189M
4
NVDA icon
NVIDIA
NVDA
+$186M
5
ORCL icon
Oracle
ORCL
+$125M

Sector Composition

Rank Sector Weight
1 Technology 30.29%
2 Communication Services 19.88%
3 Consumer Discretionary 16.67%
4 Healthcare 10.59%
5 Financials 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHM icon
326
Pultegroup
PHM
$24.7B
$11.6M 0.01%
87,533
-41,405
-32% -$5.14M
CEMB icon
327
iShares JPMorgan EM Corporate Bond ETF
CEMB
$412M
$11.5M 0.01%
249,548
+14,262
+6% +$652K
MS icon
328
Morgan Stanley
MS
$346B
$11.5M 0.01%
72,232
-2,356
-3% -$348K
PRSU
329
Pursuit Attractions and Hospitality Inc
PRSU
$1.28B
$11.5M 0.01%
316,921
+35,711
+13% +$1.21M
ICLR icon
330
Icon
ICLR
$12.7B
$11.3M 0.01%
64,711
-1,486
-2% -$249K
IWF icon
331
iShares Russell 1000 Growth ETF
IWF
$128B
$11.3M 0.01%
96,244
+5,740
+6% +$639K
AMRZ
332
Amrize Ltd
AMRZ
$25.4B
$11.2M 0.01%
231,389
+56,300
+32% +$2.87M
COLL icon
333
Collegium Pharmaceutical
COLL
$917M
$11.1M 0.01%
317,880
-19,257
-6% -$669K
POWI icon
334
Power Integrations
POWI
$3.58B
$11.1M 0.01%
275,125
-10,441
-4% -$504K
CNM icon
335
Core & Main
CNM
$8.64B
$11M 0.01%
205,019
-37,697
-16% -$2.28M
ECVT icon
336
Ecovyst
ECVT
$1.11B
$11M 0.01%
1,259,769
+209,799
+20% +$1.85M
AVA icon
337
Avista
AVA
$3.27B
$11M 0.01%
+291,415
New +$10.8M
PWP icon
338
Perella Weinberg Partners
PWP
$1.3B
$11M 0.01%
514,745
+12,398
+2% +$265K
TJX icon
339
TJX Companies
TJX
$168B
$11M 0.01%
75,786
+18,801
+33% +$2.5M
HAE icon
340
Haemonetics
HAE
$4.13B
$10.9M 0.01%
224,336
+6,688
+3% +$414K
LFST icon
341
Lifestance Health
LFST
$4.63B
$10.9M 0.01%
1,986,070
-356,958
-15% -$1.75M
CMCSA icon
342
Comcast
CMCSA
$91.4B
$10.7M 0.01%
341,458
-7,763
-2% -$260K
INSW icon
343
International Seaways
INSW
$4.74B
$10.7M 0.01%
232,266
+42,066
+22% +$1.82M
LEVI icon
344
Levi Strauss
LEVI
$8.58B
$10.7M 0.01%
458,814
+4,620
+1% +$98.2K
WLY icon
345
John Wiley & Sons Class A
WLY
$2.57B
$10.6M 0.01%
262,524
+16,392
+7% +$662K
FOUR icon
346
Shift4
FOUR
$3.72B
$10.4M 0.01%
134,348
-5,472
-4% -$509K
ST icon
347
Sensata Technologies
ST
$6.73B
$10.3M 0.01%
336,403
-25,577
-7% -$808K
ACM icon
348
Aecom
ACM
$7.8B
$10.2M 0.01%
78,437
-55,194
-41% -$6.67M
GILD icon
349
Gilead Sciences
GILD
$170B
$10.2M 0.01%
92,145
+36,524
+66% +$4.15M
HRI icon
350
Herc Holdings
HRI
$5.59B
$10.1M 0.01%
86,810
+4,971
+6% +$641K

Similar funds

Loomis, Sayles & Company's Q3 2025 Portfolio in Review

As of Q3 2025, Loomis, Sayles & Company held 789 positions worth $84.1B, up 5.4% from $79.8B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Loomis, Sayles & Company's Q3 2025 filing shows 67 new, 250 increased, 339 reduced and 77 closed positions. Its largest new stake was Extreme Networks: 2,220,998 shares worth $45.9M. The largest sale was Alibaba, an estimated $231M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Loomis, Sayles & Company's largest Q3 2025 buy was Extreme Networks: 2,220,998 shares worth $45.9M.
  • Loomis, Sayles & Company added most to Novo Nordisk in Q3 2025, an estimated $210M increase.
  • Loomis, Sayles & Company's biggest Q3 2025 reduction was Alibaba, cutting an estimated $231M.
  • Loomis, Sayles & Company fully exited Clearwater Analytics in Q3 2025, selling an estimated $58M.
  • Loomis, Sayles & Company's ten largest holdings make up 54% of its $84.1B portfolio in Q3 2025.
  • Loomis, Sayles & Company opened 67 new positions and closed 77 in Q3 2025.
  • Loomis, Sayles & Company's portfolio value rose 5.4% quarter-over-quarter to $84.1B.

Based on Loomis, Sayles & Company's 13F filing for Q3 2025, filed 13 Nov 2025.